Kyowa Kirin Pharmaceutical Development Ltd
Clinical trials sponsored by Kyowa Kirin Pharmaceutical Development Ltd, explained in plain language.
Pharmaceutical company developing treatments for rare diseases and oncology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
What It's really like: teens with XLH share their journey as bones stop growing
Knowledge-focused CompletedThis study follows about 25 adolescents aged 12–17 with X-Linked Hypophosphatemia (XLH) who are being treated with burosumab and are nearing the end of their skeletal growth. Researchers will track symptoms, activity levels, and overall burden through surveys and interviews over …
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Real-World study tracks Poteligeo's impact on rare skin cancer symptoms
Knowledge-focused CompletedThis completed observational study followed 73 adults with mycosis fungoides or Sézary syndrome who were starting treatment with Poteligeo. Researchers tracked changes in symptoms like itching, skin pain, and fatigue, as well as quality of life for patients and their caregivers. …
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC